Clinical outcome and toxicity of stereotactic ablative radiotherapy to centrally located tumors.

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAtalar, B.
dc.contributor.authorSahin, B.
dc.contributor.authorMustafayev, T. Zoto
dc.contributor.authorGungor, G.
dc.contributor.authorAydin, G.
dc.contributor.authorYapici, B.
dc.contributor.authorOzyar, E.
dc.date.accessioned2023-02-21T12:32:26Z
dc.date.available2023-02-21T12:32:26Z
dc.date.issued2018-01-01
dc.description.issue1
dc.description.issueAPR
dc.description.pagesS765
dc.description.volume127
dc.identifier.doi10.1016/S0167-8140(18)31712-2
dc.identifier.urihttps://hdl.handle.net/11443/1071
dc.identifier.urihttp://dx.doi.org/10.1016/S0167-8140(18)31712-2
dc.identifier.wosWOS:000438676100200
dc.publisherELSEVIER IRELAND LTD
dc.relation.ispartofRADIOTHERAPY AND ONCOLOGY
dc.titleClinical outcome and toxicity of stereotactic ablative radiotherapy to centrally located tumors.
dc.typeArticle

Dosyalar

Orijinal seri

Şimdi gösteriliyor 1 - 1 / 1
Thumbnail Image
Ad:
10.1016S0167-8140(18)31712-2.pdf
Boyut:
582.46 KB
Format:
Adobe Portable Document Format
İndir

Koleksiyonlar

WOS